Share this article
Share this article
ATLANTA, Feb. 9, 2021 /PRNewswire/ Covanos, Inc., a privately-held medical technology company that is developing C-HEART, a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively diagnose the severity of coronary artery blockages, today announced that it has named Mark D. Carlson, MD, MA to the position of Senior Vice President and Chief Medical Officer. We are pleased to welcome Mark Carlson to the Covanos team, said Russell M. Medford, M.D., Ph.D., chairman and chief executive officer of Covanos. Mark s executive experience in developing and commercializing cardiac medical technology for some of the largest global businesses in the field positions Covanos well as we transition to a commercial enterprise later this year and pursue our mission to serve patients and reduce global healthcare costs.